Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Interest & Investment Income (2016 - 2023)

Historic Interest & Investment Income for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to $7.1 million.

  • RedHill Biopharma's Interest & Investment Income rose 32689.53% to $7.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $40.6 million, marking a year-over-year increase of 228489.12%. This contributed to the annual value of $8.4 million for FY2024, which is 5978.27% down from last year.
  • RedHill Biopharma's Interest & Investment Income amounted to $7.1 million in Q2 2023, which was up 32689.53% from $21.6 million recorded in Q1 2023.
  • RedHill Biopharma's Interest & Investment Income's 5-year high stood at $21.6 million during Q1 2023, with a 5-year trough of -$214000.0 in Q1 2020.
  • For the 5-year period, RedHill Biopharma's Interest & Investment Income averaged around $2.5 million, with its median value being $139000.0 (2019).
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 15721.93% in 2020, then surged by 21572000.0% in 2023.
  • Quarter analysis of 5 years shows RedHill Biopharma's Interest & Investment Income stood at $260000.0 in 2019, then plummeted by 126.54% to -$69000.0 in 2020, then surged by 117.39% to $12000.0 in 2021, then skyrocketed by 72400.0% to $8.7 million in 2022, then decreased by 18.45% to $7.1 million in 2023.
  • Its Interest & Investment Income was $7.1 million in Q2 2023, compared to $21.6 million in Q1 2023 and $8.7 million in Q4 2022.